【用戶】霸氣阿宏

【年級】小二上

【評論內容】●Oral contraceptives (OCs) are the mainstay of pharmacologic therapy for women with PCOS for managing hyperandrogenism and menstrual dysfunction and for providing contraception.●Our approach to the use of OCs in women with PCOS is the same as that for women without PCOS. Risk factors for venous thromboembolism (VTE) including obesity, patient age, and family history of VTE should be assessed. More information can be found in the Centers for Disease Control and Prevention United States Medical Eligibility Criteria for Contraceptive Use.We suggest caution when prescribing OCs in obese women (...